Price
Financials
Standalone, Rs crore| Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 95 | 104 | 107 | 106 | 149 | 116 | 103 | 135 | 114 | 136 | 120 | 145 |
| Expenses | 90 | 93 | 89 | 98 | 130 | 105 | 98 | 121 | 111 | 122 | 112 | 148 |
| Operating Profit | 5 | 11 | 18 | 8 | 18 | 11 | 4 | 15 | 3 | 14 | 8 | -3 |
| OPM % | 5% | 11% | 17% | 8% | 12% | 10% | 4.4% | 11% | 2.8% | 11% | 7% | -2.0% |
| Other Income | 2 | 1 | 3 | 67 | 6 | 3 | 3 | 46 | 40 | 5 | 2 | 281 |
| Interest | 15 | 15 | 15 | 14 | 15 | 18 | 15 | 14 | 10 | 10 | 10 | 10 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | 5 | 6 | 7 |
| Profit before tax | -15 | -11 | -1 | 53 | 2 | -11 | -15 | 40 | 28 | 4 | -6 | 261 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 6% | 0% | 0% | 0% | 2% |
| Net Profit | -15 | -11 | -1 | 53 | 2 | -11 | -15 | 38 | 28 | 4 | -6 | 257 |
| EPS in Rs | -2.85 | -1.95 | -0.19 | 9.80 | 0.44 | -1.98 | -2.76 | 6.93 | 5.21 | 0.76 | -1.01 | 47.34 |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 417 | 308 | 263 | 270 | 289 | 330 | 356 | 398 | 411 | 502 | 515 |
| Expenses | 602 | 487 | 465 | 328 | 262 | 278 | 306 | 315 | 352 | 369 | 448 | 492 |
| Operating Profit | -32 | -70 | -157 | -65 | 8 | 11 | 23 | 41 | 45 | 42 | 54 | 23 |
| OPM % | -6% | -17% | -51% | -25% | 2.9% | 3.7% | 7% | 12% | 11% | 10% | 11% | 4.5% |
| Other Income | 11 | 2 | 13 | -246 | -20 | 34 | 22 | 14 | 24 | 72 | 53 | 328 |
| Interest | 77 | 40 | 19 | 16 | 7 | 3 | 29 | 52 | 57 | 60 | 63 | 39 |
| Depreciation | 26 | 39 | 36 | 36 | 35 | 34 | 34 | 33 | 32 | 29 | 27 | 24 |
| Profit before tax | -124 | -147 | -200 | -363 | -53 | 8 | -17 | -29 | -20 | 26 | 16 | 288 |
| Tax % | -7% | -2% | 0% | 0% | 1% | 0% | 15% | 1% | 2% | 0% | 14% | 2% |
| Net Profit | -116 | -145 | -200 | -364 | -54 | 8 | -19 | -30 | -20 | 26 | 14 | 283 |
| EPS in Rs | -22.97 | -28.85 | -39.75 | -67.21 | -9.99 | 1.51 | -3.53 | -5.50 | -3.69 | 4.80 | 2.63 | 52.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 2% | 9% | 9% | 3% | ||
| Compounded Profit Growth | 7% | 18% | 33% | 132% | ||
| Stock Price CAGR | 13% | 10% | -7% | 0% | ||
| Return on Equity | % | % | % | % |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 84 | -64 | -264 | -636 | -690 | -688 | -724 | -706 | -731 | -716 | -702 | -413 |
| Borrowings | 1,024 | 1,054 | 1,061 | 1,062 | 1,055 | 1,010 | 1,017 | 1,023 | 1,036 | 993 | 1,014 | 874 |
| Other Liabilities | 272 | 228 | 254 | 232 | 237 | 265 | 298 | 344 | 316 | 361 | 331 | 257 |
| Total Liabilities | 1,390 | 1,228 | 1,061 | 669 | 613 | 598 | 602 | 672 | 632 | 649 | 654 | 728 |
| Fixed Assets | 440 | 404 | 374 | 342 | 311 | 291 | 270 | 244 | 236 | 216 | 184 | 243 |
| CWIP | 4 | 4 | 4 | 2 | 0 | 0 | 0 | 13 | 9 | 30 | 51 | 0 |
| Investments | 45 | 45 | 45 | 44 | 44 | 41 | 24 | 70 | 64 | 54 | 1 | 6 |
| Other Assets | 900 | 775 | 638 | 281 | 258 | 267 | 308 | 344 | 323 | 349 | 418 | 480 |
| Total Assets | 1,390 | 1,228 | 1,061 | 669 | 613 | 598 | 602 | 672 | 632 | 649 | 654 | 728 |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 103 | 86 | -106 | 7 | 1 | 43 | 35 | 83 | 50 | 73 | 15 | 16 |
| Cash from Investing Activity | -14 | -6 | -4 | -4 | -3 | -14 | -11 | -17 | -18 | -29 | 77 | 3 |
| Cash from Financing Activity | -89 | -81 | 110 | -11 | -4 | -13 | -26 | -54 | -45 | -47 | -42 | -13 |
| Net Cash Flow | 0 | -1 | 0 | -8 | -5 | 16 | -3 | 12 | -13 | -3 | 50 | 6 |
| Free Cash Flow | 88 | 80 | -110 | 2 | -5 | 29 | 22 | 63 | 31 | 42 | -13 | -25 |
| CFO/OP | -320% | -122% | 67% | -10% | 17% | 397% | 148% | 202% | 111% | 174% | 28% | 69% |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 282 | 425 | 451 | 151 | 113 | 95 | 104 | 111 | 83 | 93 | 111 | 112 |
| Inventory Days | 202 | 117 | 151 | 86 | 108 | 112 | 102 | 123 | 120 | 150 | 83 | 150 |
| Days Payable | 152 | 155 | 290 | 356 | 426 | 454 | 440 | 454 | 353 | 393 | 262 | 143 |
| Cash Conversion Cycle | 331 | 387 | 311 | -119 | -206 | -246 | -234 | -220 | -149 | -150 | -68 | 120 |
| Working Capital Days | 94 | 2 | -32 | -570 | -563 | -558 | -490 | -482 | -451 | -601 | -30 | 35 |
| ROCE % | -4% | -10% | -20% | -14% | -4% | -4% | 2% | 8% | 11% | 8% | 13% | 12% |
| Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% | 55.58% |
| Public | 44.42% | 44.40% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.43% | 44.42% | 44.42% |
| No. of Shareholders | 14,422 | 14,927 | 14,785 | 14,590 | 13,745 | 14,219 | 16,438 | 17,440 | 18,028 | 20,936 | 21,368 | 21,588 |
Fundamentals
Market Cap₹ 85.4 Cr.
Current Price₹ 15.8
Stock P/E10.9
Book Value₹ -74.2
ROCE11.9 %
ROE%
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)3%
Compounded Profit Growth (TTM)132%
Standalone figures.
Valuation
Market capRs 85 Cr
Enterprise valueRs 890 Cr
P/E (TTM)0.30x
Price to book-0.21x
Price to sales0.17x
EV / EBITDA2.54x
EV / EBIT2.72x
EV / sales1.73x
Price to cash flow5.38x
Earnings yield332.06%
P/E, 3-year average4.24x
P/B, 3-year average-0.10x
P/E, 5-year average4.24x
P/B, 5-year average-0.08x
Profitability
Operating margin (excl. other income)4.46%
Operating margin (incl. other income)68.04%
EBITDA margin68.04%
Pre-tax margin55.88%
Net profit margin55.01%
Net margin, latest quarter177.09%
ROE-51.86%
ROCE82.33%
ROA41.01%
ROE, 3-year average-19.18%
ROCE, 3-year average45.59%
ROA, 3-year average15.75%
ROE, 5-year average-10.10%
ROCE, 5-year average31.13%
ROA, 5-year average7.90%
ROIC (approx.)80.12%
Tax rate1.55%
Other income / net worth-81.42%
Growth
Sales growth (latest year)2.58%
Profit growth (latest year)1891.92%
Sales CAGR, 3 years9.01%
Sales CAGR, 5 years9.35%
Sales growth QoQ20.62%
Sales growth YoY (latest quarter)7.15%
Profit growth YoY (latest quarter)583.54%
Per share
EPS (TTM)Rs 52.33
EPS (latest quarter)Rs 47.38
EPS, 3-year averageRs 3.72
EPS, 5-year averageRs -0.44
Book value per shareRs -74.28
Sales per shareRs 95.13
Cash flow per shareRs 2.93
Free cash flow per shareRs -4.62
Efficiency
Asset turnover0.71x
Fixed asset turnover2.12x
Inventory turnover2.43x
Inventory days150 days
Debtor days112 days
Debtors turnover3.25x
Creditor days143 days
Cash conversion cycle120 days
Working capital days35 days
Leverage
Total debtRs 874 Cr
Cash and bankRs 70 Cr
Net debtRs 804 Cr
Debt to equity-2.17x
Net debt / EBITDA2.29x
Interest coverage8.35x
Owners' fund to total sources-55.27%
Debt to assets120.03%
Cash flow
Cash from Operating Activity (latest year)Rs 16 Cr
Cash from Investing Activity (latest year)Rs 3 Cr
Cash from Financing Activity (latest year)Rs -13 Cr
Net Cash Flow (latest year)Rs 6 Cr
Free cash flow (latest year)Rs -25 Cr
FCFE (approx.: FCF + change in debt)Rs -165 Cr
Cash from ops / profit, 5 years0.87x
Sales to cash flow32.49x
Statement figures
Net sales (TTM)Rs 515 Cr
Net sales (latest year)Rs 515 Cr
Sales (latest quarter)Rs 145 Cr
Operating profit excl. other income (latest year)Rs 23 Cr
Operating profit (latest quarter)Rs -3 Cr
Other income (TTM)Rs 328 Cr
EBITDA (TTM)Rs 351 Cr
PBDT (TTM)Rs 311 Cr
Profit before tax (TTM)Rs 288 Cr
Tax (latest year)Rs 4 Cr
Net profit (TTM)Rs 283 Cr
Net profit (latest year)Rs 283 Cr
Net profit (latest quarter)Rs 257 Cr
Depreciation (TTM)Rs 24 Cr
Depreciation (latest quarter)Rs 7 Cr
Interest (TTM)Rs 39 Cr
Cost of goods sold (latest year)Rs 260 Cr
Total expenditure (latest year)Rs 492 Cr
Total income (latest year)Rs 843 Cr
Share capitalRs 11 Cr
ReservesRs -413 Cr
Shareholders' fundsRs -402 Cr
Total assetsRs 728 Cr
Net blockRs 243 Cr
InvestmentsRs 6 Cr
ReceivablesRs 159 Cr
InventoryRs 107 Cr
Other liabilitiesRs 257 Cr
Shares outstanding (crore)5.42
Ownership
Promoter holding55.58% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 0.3 is the lowest in its own 3.2-year history
(median 2.5, low 0.3, high 10.3).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | INDSWFTLTD | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.3% | -2.8% | +1.5 pts |
| 1 month | -16.7% | -6.8% | -9.9 pts |
| 3 months | +7.0% | -7.6% | +14.6 pts |
| 6 months | -0.8% | +0.4% | -1.2 pts |
| 1 year | -36.5% | -9.9% | -26.6 pts |
| 2 years | +31.3% | -13.6% | +44.9 pts |
| 3 years | +58.4% | +14.2% | +44.2 pts |
| 5 years | +443.4% | +27.9% | +415.6 pts |
Red flags
F-score 5 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | Weak cash conversion Cash from operations was 32% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 37% of total assets in 2025 |
| look | Inventory outrunning sales Inventory grew 67% vs sales +3% in 2025 |
| look | Profit leans on other income Other income was 114% of pre-tax profit in 2025 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2025Sales ₹145 Cr +7.4% vs Mar 2024.
Net profit ₹257 Cr +576.3%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2024-09-23 | Annual General Meeting | |
| 2023-09-22 | Annual General Meeting | |
| 2022-09-13 | Annual General Meeting | |
| 2021-09-23 | Annual General Meeting | |
| 2020-09-24 | Annual General Meeting | |
| 2019-09-05 | Annual General Meeting | |
| 2018-09-19 | Annual General Meeting | |
| 2017-09-14 | Annual General Meeting | |
| 2016-09-20 | Annual General Meeting | |
| 2015-09-18 | Annual General Meeting | |
| 2014-09-18 | Annual General Meeting | |
| 2013-09-25 | Annual General Meeting | |
| 2012-12-18 | Annual General Meeting | |
| 2011-09-21 | Annual General Meeting And Dividend Re.0.40 Per Share | |
| 2010-09-24 | Annual General Meeting And Dividend Re.0.40 Per Share | |
| 2009-09-17 | Agm/Div-Re.0.40 Per Share | |
| 2008-09-19 | Agm/Dividend - 20% | |
| 2007-09-21 | Agm/Dividend-20% | |
| 2006-09-28 | Agm/Dividend-20% |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Ind-Swift Ltd?
Ind-Swift Ltd (INDSWFTLTD) has a market capitalisation of Rs 85.4 Cr. at the 2025-08-13 close.
What is the P/E ratio of Ind-Swift Ltd?
Ind-Swift Ltd trades at a P/E of 10.9 on trailing twelve-month profit, at the 2025-08-13 close.
What were Ind-Swift Ltd's latest quarterly results?
In the Mar 2025 quarter, Ind-Swift Ltd sales was Rs 145 Cr (+7.4% vs Mar 2024) and net profit was Rs 257 Cr.